Table 1.
Demographic and clinical data
| Steroid group | Nonsteroid group | p | |
|---|---|---|---|
| Females/males (n) | 8/5 | 8/3 | 0.68 |
| Age (years) | 59.4 ± 1.5 | 50.3 ± 2.2 | 0.002 |
| Education (years) | 9.0 ± 0.4 | 10.4 ± 0.8 | 0.13 |
| ESR | 10.4 ± 2.4 | 13.6 ± 1.9 | 0.33 |
| DAS28 | 3.1 ± 0.5 | 3.4 ± 0.3 | 0.56 |
| RADAI | 3.1 ± 0.4 | 3.1 ± 0.5 | 0.98 |
| MADRS | 5.7 ± 2.0 | 5.2 ± 1.3 | 0.84 |
| Disease duration (months) | 147.2 ± 43.6 | 175.8 ± 27.6 | 0.60 |
| Dose of chronic prednisone medication (mg) | 7.5 ± 0.8 | ||
| Duration of chronic prednisone medication (months) | 63.7 ± 11.8 |
Data are presented as mean ± SE. Steroid group, Group with chronic prednisone medication; nonsteroid group, group without chronic glucocorticoid medication; ESR, Erythrocyte Sedimentation Rate; DAS28, Disease Activity Score; RADAI, Rheumatoid Arthritis Disease Activity Index; MADRS, Montgomery Asberg Depression Scale.